Topical Corticosteroid Therapy for Corneal Toxicity from Systemically Administered Cytarabine
- 1 November 1982
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 94 (5) , 617-621
- https://doi.org/10.1016/0002-9394(82)90006-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Central nervous system toxicity of high-dose systemic cytosine arabinosideCancer, 1981
- Corneal Toxicity with Systemic CytarabineAmerican Journal of Ophthalmology, 1981
- The cytosine arabinoside (Ara‐C) syndromeMedical and Pediatric Oncology, 1981
- Acute Leukemia: Biology and TreatmentAnnals of Internal Medicine, 1979
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Progress in the Treatment of Adults With Acute LeukemiaArchives of internal medicine (1960), 1976
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Studies with Cytarabine HCL (CA)American Journal of Ophthalmology, 1965
- Corneal Toxicity of Cytosine ArabinosideArchives of Ophthalmology (1950), 1964